semaglutide
Explore Prescription Weight Loss 3 GLP‑1 Breakthroughs
Three next-gen GLP-1 drugs - semaglutide, tirzepatide and emerging oral or implant forms - are reshaping obesity treatment by delivering greater weight loss, better cardiovascular outcomes and improved adherence. In 2024, GLP-1 prescriptions generated a 30% increase in average weight loss compared with diet alone, translating to roughly 0.4